The international liquid biopsy sector is seeing substantial increase, driven by advancements in cancer detection and personalized medicine. Current assessments value the market valuation at around USD X.X billion dollars in the current year, with predictions pointing to a compound annual CAGR of Y.Z percent through 2033. Dominant trends feature… Read More